CHOLECYSTOKININ ATTENUATES BASAL AND DRUG-INDUCED INCREASES OF LIMBIC AND STRIATAL DOPAMINE RELEASE

被引：39

作者：

ALTAR, CA ^{[1
]}

BOYAR, WC ^{[1
]}

OEI, E ^{[1
]}

WOOD, PL ^{[1
]}

机构：

[1] CIBA GEIGY CORP,DEPT NEUROSCI,DIV PHARMACEUT,SUMMIT,NJ 07901

来源：

BRAIN RESEARCH | 1988年 / 460卷 / 01期

关键词：

D O I：

10.1016/0006-8993(88)90431-3

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：76 / 82

页数：7

共 47 条

[1] SENSORIMOTOR IMPAIRMENT AND ELEVATED LEVELS OF DOPAMINE METABOLITES IN THE NEOSTRIATUM OCCUR RAPIDLY AFTER INTRANIGRAL INJECTION OF 6-HYDROXYDOPAMINE OR GAMMA-HYDROXYBUTYRATE IN AWAKE RATS
ALTAR, CA
ONEIL, S
MARSHALL, JF
[J]. NEUROPHARMACOLOGY, 1984, 23 (03) : 309 - 318
[2] ALTAR CA, 1987, EUR J PHARMACOL, V134, P303
[3] [Anonymous], 1971, STAT PRINCIPLES EXPT
[4] REVERSAL BY CHOLECYSTOKININ OF APOMORPHINE-INDUCED INHIBITION OF DOPAMINE RELEASE IN THE NUCLEUS-ACCUMBENS OF THE RAT
BLAHA, CD
PHILLIPS, AG
LANE, RF
[J]. REGULATORY PEPTIDES, 1987, 17 (06) : 301 - 310
[5] MODULATION OF INVIVO DOPAMINE RELEASE BY D-2 BUT NOT D-1 RECEPTOR AGONISTS AND ANTAGONISTS
BOYAR, WC
ALTAR, CA
[J]. JOURNAL OF NEUROCHEMISTRY, 1987, 48 (03) : 824 - 831
[6] FURTHER-STUDIES ON THE SPECIFICITY OF PROGLUMIDE AS A SELECTIVE CHOLECYSTOKININ ANTAGONIST IN THE CENTRAL NERVOUS-SYSTEM
BUNNEY, BS
CHIODO, LA
FREEMAN, AS
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 448 (JUL) : 345 - 351
[7] INCREASE IN BRAIN I-125-LABELED CHOLECYSTOKININ (CCK) RECEPTOR-BINDING FOLLOWING CHRONIC HALOPERIDOL TREATMENT, INTRACISTERNAL 6-HYDROXYDOPAMINE OR VENTRAL TEGMENTAL LESIONS
CHANG, RSL
LOTTI, VJ
MARTIN, GE
CHEN, TB
[J]. LIFE SCIENCES, 1983, 32 (08) : 871 - 878
[8] Connell PH, 1958, AMPHETAMINE PSYCHOSI
[9] REDUCED HIGH-AFFINITY CHOLECYSTOKININ BINDING IN HIPPOCAMPUS AND FRONTAL-CORTEX OF SCHIZOPHRENIC-PATIENTS
FARMERY, SM
OWEN, F
POULTER, M
CROW, TJ
[J]. LIFE SCIENCES, 1985, 36 (05) : 473 - 477
[10] FERRIER IN, 1983, LIFE SCI, V33, P475

← 1 2 3 4 5 →